Medicine
Meperidine 100 mg/1 mL injection
Meperidine 100 mg/1 mL injection is a generic prescription medicine for intramuscular, intravenous, subcutaneous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 ° to 25 °C (68 ° to 77 °F), excursions permitted to 15 ° to 30 °C…
Key facts
- Active ingredient (INN)
- Meperidine
- Brand
- Sold under the generic name
- Strength
- 100 mg/1 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous, subcutaneous
- Packs
- 25 vials of 1 mL
- Manufacturer
- Hikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20 ° to 25 °C (68 ° to 77 °F), excursions permitted to 15 ° to 30 °C (59 ° to 86 °F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CII
- ATC code
- N02AB02 Meperidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 January 1975
- Identifiers
- RxCUI 861476, 1665685, 1665697DailyMed set ID e0e998da-f056-4fce-be8e-ed60cf3b461bNDC 0641-6054Application ANDA080445
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial in 1 carton / 1 mL in 1 vial | 0641-6054-25 | Hikma Pharmaceuticals | 22 January 1975 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 November 1942 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Meperidine
Clinical summary
Meperidine is an opioid agonist indicated for preoperative medication, support of anesthesia, and obstetrical analgesia, among other approved uses. It is available as injection, tablets and oral solution for intramuscular, intravenous and subcutaneous use. MedsAcross supplies Meperidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MeperidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DEMEROL prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
Need Meperidine 100 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.